Ewing’s Sarcoma in a 58-Year-Old Man: Challenges of Cancer Diagnosis During the COVID-19 Era
Open Access
- 1 January 2022
- journal article
- Published by Polaris in Archive of International Journal of Cancer and Allied Science
- Vol. 2 (1) , 37-41
Abstract
Ewing's sarcoma, a rare and highly aggressive tumor, is prone to recurrence even after extensive surgery and often metastasizes early. Typically seen in children and adolescents aged 10-20 years, it affects older individuals in approximately 30% of cases. This report details a 58-year-old man presenting with a foot tumor, back pain, and left leg discomfort. A chest x-ray revealing a lung mass led to a referral to the Pulmonology Department, but the diagnosis was delayed for months, worsening the prognosis of this aggressive malignancy. The COVID-19 pandemic has significantly disrupted global healthcare, redirecting resources and delaying the diagnosis of non-COVID conditions. This has resulted in more patients presenting with advanced disease, limiting treatment options. Patient fear of infection further complicates timely diagnosis. This case underscores the impact of the pandemic on oncology care.Keywords
This publication has 12 references indexed in Scilit:
- Prevalence of insomnia and anxiety among healthcare workers during the COVID-19 pandemic in Jilin ProvinceBrazilian Journal of Medical and Biological Research, 2021
- Clinical Outcome of Systemic Treatment for Advanced Soft Tissue Sarcoma: Real-Life Perspective in JapanDrug Design, Development and Therapy, 2020
- COVID-19 threatens to cause collateral delay in cancer diagnosisSao Paulo Medical Journal, 2020
- Resuming bowel cancer screening post-COVID-19The Lancet Gastroenterology & Hepatology, 2020
- The impact of the COVID-19 pandemic on cancer deaths due to delays in diagnosis in England, UK: a national, population-based, modelling studyThe Lancet Oncology, 2020
- The impact of the COVID-19 pandemic on cancer careNature Cancer, 2020
- Geographical Accessibility of the Sarcoma Referral Networks in France. Intermediate Results from the IGéAS Research ProgramInternational Journal of Environmental Research and Public Health, 2018
- Changes in Incidence and Survival of Ewing Sarcoma Patients Over the Past 3 DecadesJournal of Pediatric Hematology/Oncology, 2008
- The Ewing’s sarcoma family of tumors: Ewing’s sarcoma and peripheral primitive neuroectodermal tumor of bone and soft tissue1997
- Multimodal therapy for the management of primary, nonmetastatic Ewing's sarcoma of bone: a long-term follow-up of the First Intergroup study.Journal of Clinical Oncology, 1990